Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
192,975,286
-
Total 13F shares
-
179,051,547
-
Share change
-
-3,393,461
-
Total reported value
-
$17,400,388,762
-
Put/Call ratio
-
52%
-
Price per share
-
$97.24
-
Number of holders
-
544
-
Value change
-
-$352,972,540
-
Number of buys
-
260
-
Number of sells
-
259
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2023
As of 31 Mar 2023,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
544 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
179,051,547 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, Capital Research Global Investors, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, and BANK OF AMERICA CORP /DE/.
This page lists
544
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.